AlphaQuest’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-79,130
Closed -$1.5M 1706
2025
Q4
$1.5M Sell
79,130
-65,709
-45% -$1.22M 0.08% 276
2025
Q3
$2.7M Buy
144,839
+109,444
+309% +$2.04M 0.18% 123
2025
Q2
$653K Buy
35,395
+19,811
+127% +$352K 0.06% 481
2025
Q1
$272K Sell
15,584
-19,787
-56% -$334K 0.03% 830
2024
Q4
$613K Buy
35,371
+33,942
+2,375% +$620K 0.08% 389
2024
Q3
$26.6K Sell
1,429
-12,525
-90% -$211K ﹤0.01% 1488
2024
Q2
$215K Buy
13,954
+13,916
+36,621% +$199K 0.03% 720
2024
Q1
$561 Sell
38
-19,147
-100% -$265K ﹤0.01% 1488
2023
Q4
$274K Buy
+19,185
New +$272K 0.06% 550

Other funds holding SBRA

AlphaQuest's SBRA Position: Q1 2026 in Review

AlphaQuest sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 79,130 shares — an estimated $1.5M sold.

AlphaQuest first reported a position in SBRA in Q4 2023 and held it in 9 quarters. The position peaked at $2.7M in Q3 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • AlphaQuest reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 79,130 Sabra Healthcare REIT shares in Q1 2026, an estimated $1.5M.
  • AlphaQuest first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Sabra Healthcare REIT position peaked at $2.7M in Q3 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.